The Laboratory of Paul Sondel, MD, PhD, will soon begin a collaboration with Invenra, Inc., a biotechnology company focused on the discovery and development of multispecific antibodies for immuno-oncology, and Wisconsin Alumni Research Foundation (WARF). This collaboration, planned for two years and worth an estimated $400,000 in direct costs to Dr. Sondel’s lab, will foster discovery and development of a bispecific antibody therapeutic for the treatment of neuroblastoma. The idea for this collaboration emerged from a previous collaboration between Invenra and Dr. Sondel. See link to full story: https://pipelinereview.com/index.php/2019020170435/More-News/Invenra-and-WARF-Initiate-a-Collaboration-to-Discover-and-Develop-Novel-Therapeutics-to-Fight-Neuroblastoma-in-Children.html